12:42am Tuesday 17 September 2019

Saint Louis University Studies an Investigational Drug to Treat Generalized Anxiety Disorder

Professor of psychiatry George Grossberg, M.D. is the principal investigator of the study.

Generalized anxiety disorder is the most common cause of anxiety symptoms in adults and can affect 3.1 percent of the population in any given year, says George Grossberg, M.D., professor of psychiatry and principal investigator for the study at Saint Louis University.

“People who have generalized anxiety disorder show excessive amounts of anxiety, worry and preoccupation on a number of different things, on a day-to-day basis for at least six months,” said Grossberg.

According to Grossberg, the extreme amount of anxiety is difficult to control, which can cause difficulty sleeping, lack of energy, difficulty concentrating or focusing, and irritable and tense feelings.

Treatment approaches for generalized anxiety disorder typically involve medication, cognitive therapy or a combination of the two.

Investigators will enroll men and women who are 18 to 70 years old who have been diagnosed with generalized anxiety disorder in this randomized, double-blind, placebo-controlled study.

Participants will take one of two daily doses of the investigational product or placebo. The effectiveness and safety of the investigational drug will be evaluated through eight clinical visits over the course of 10 weeks.

Saint Louis University hopes to enroll at least 10 participants for the trial and is the only study center in the St. Louis area. A total of 660 patients will be randomized into three groups across approximately 40 study centers.

To learn more about the study and inclusion criteria, contact Susan Brown at 314-977-4818 and reference IRB number 22482.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious diseases.

Share on:

Health news